Back to search

France· FR:62133146

RAMET DALIBOUR, solution pour application locale

A medicinal product, registered in France by TRADIPHAR.

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedRAMET DALIBOUR, solution pour applica…ATC—REGISTER NO.FR:62133146PACKS LISTED1CHECKEDJune 3, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Manufacturer
TRADIPHAR
Country
France (FR)
ATC code
—
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
June 3, 2026

Packs & prices · 1

  • cip13
    3400933657369
    1 flacon(s) polyéthylène haute densité (PEHD) de 250 ml

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fc7fa514-5166-483f-8995-8f7aa0afcd76
GET /v1/drugs/fc7fa514-5166-483f-8995-8f7aa0afcd76?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "62133146",
  "date_amm": "1995-11-14",
  "type_amm": "Procédure nationale",
  "numero_ue": null,
  "statut_amm": "Autorisation abrogée",
  "statut_bdm": "Warning disponibilité",
  "forme_pharmaceutique": "solution pour application",
  "voies_administration": "cutanée",
  "etat_commercialisation": "Non commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about RAMET.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.